FlandersBio on Twitter

Follow us on Twitter

Archive for July 2013 - News

Archive for July 2013 - Nieuws

in het nederlands in english

FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.

FlandersBio informeert u over belangrijk nieuws op het vlak van de biowetenschappen. Bezorg ons jouw nieuwtjes. Als het interessant is voor de sector, zullen wij het op onze website plaatsen.

KU LEUVEN AND FIT BIOTECH ENTER INTO A WORLDWIDE LICENSE AND COLLABORATION AGREEMENT FOR THE DEVELOPMENT OF NOVEL IMMUNOTHERAPEUTICS

30.07.2013

KU Leuven and FIT Biotech today announced that they entered into a worldwide license and collaboration agreement for the development of novel immunotherapeutics based on FIT Biotech's proprietary Gene Transport Unit (GTU) technology for transient in vivo expression of monoclonal antibodies. The agreement provides KU Leuven with an exclusive worldwide license to six undisclosed proprietary antibodies or marketed recombinant products. read more

MDxHealth Establishes Agreements with MultiPlan and Three Rivers Provider Network for ConfirmMDxTM for Prostate Cancer

30.07.2013

MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support the diagnosis and treatment of cancer patients, today announced that it has entered into agreements with MultiPlan and Three Rivers Provider Network (TRPN). The two agreements provide expanded access to the company's ConfirmMDx for Prostate Cancer test to the networks' combined 67 million covered lives within the United States. read more

Altran Foundation for Innovation launches the 2013 Award in Belgium

30.07.2013

The Altran Foundation for Innovation launches in Belgium its 2013 Award for safe, sustainable & healthy food. read more

Niqel Lda. joins the technology platforms of QUINVITA to further develop its Jatropha farm

29.07.2013

Niqel Lda., a Mozambique based company active in the production of renewable energy from Jatropha curcas has signed a license and services agreement with QUINVITA. This agreement provides access to the QUINVITA advanced agronomy know how and to seed of the best QUINVITA (QVP) cultivars of Jatropha curcas. read more

MDxHealth and Bostwick Laboratories Announce Marketing Agreement for ConfirmMDx(TM) for Prostate Cancer

29.07.2013

MDxHealth SA (NYSE Euronext: MDXH) and Bostwick Laboratories, Inc. today announced that they have entered into a marketing agreement to commercialize MDxHealth's ConfirmMDx for Prostate Cancer test. Bostwick Laboratories is a national, full-service laboratory specializing in anatomic and clinical pathology, with a focus on uropathology. The agreement provides MDxHealth with access to one of the largest urology networks in the United States. read more

TiGenix Completes EUR 6.5 million Capital Increase

26.07.2013

TiGenix NV (Euronext Brussels: TIG) announces today the successful completion of the EUR 6.5 million capital increase announced on July 17 and 18, 2013. In total, 26 million new shares were issued. read more

Join E-news

Interested in a regular update of the life sciences and biotech sector in Flanders? Subscribe to our newsletter.

Subscribe now

Back to top

Print